# Fampridine Pregnancy Exposure Registry

> **NCT01532154** · — · TERMINATED · sponsor: **Biogen** · enrollment: 1 (actual)

## Conditions studied

- Multiple Sclerosis
- Pregnancy

## Interventions

- **DRUG:** Fampridine

## Key facts

- **NCT ID:** NCT01532154
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2015-08
- **Primary completion:** 2016-02
- **Final completion:** 2016-02
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Due to low enrollment, registration closed in agreement with the Regulatory Agency
- **Last updated:** 2016-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01532154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01532154, "Fampridine Pregnancy Exposure Registry". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01532154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*